Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer

European Journal of Gynaecological Oncology

Volumn 26, Issue 5, 2005, Pages 531-532

  Yokoyama, Y ^a   Shigeto, T ^a   Futagami, M ^a   Mizunuma, H ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Carboplatin; Ovarian cancer; Paclitaxel; SIADH

Indexed keywords

CARBOPLATIN; CISPLATIN; DEXAMETHASONE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; PACLITAXEL; SODIUM; VASOPRESSIN;

ADULT; ARTICLE; BLOOD CHEMISTRY; CANCER CHEMOTHERAPY; CASE REPORT; CONSCIOUSNESS; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MENTAL FUNCTION; OVARY CANCER; PLASMA OSMOLARITY; RECURRENT CANCER; SODIUM BLOOD LEVEL; URINE OSMOLALITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INAPPROPRIATE ADH SYNDROME; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 27744586690     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bartter F.C., Schwartz W.B.: "The syndrome of inappropriate secretion of antidiuretic hormone". Am. J. Med., 1967, 42, 790.
2. Levin L., Sealy R., Barren J.: "Syndrome of inappropriate antidiuretic hormone secretion following cis-dichlorodiammineplatiunum II in a patient with malignant thymoma". Cancer, 1982, 50, 2279.
3. Ritch P.S.: "Cis-dichlorodiammineplatinum II-induced syndrome of inappropriate secretion of antidiuretic hormone". Cancer, 1988, 61, 448.
4. Otsuka E, Hayashi Y., Oguri T., Hayakawa N., Iceda S., Makino H., Ota Z.: "Syndrome of inappropriate secretion of antidiuretic hormone following intra-theracic cisplatin". Intern. Med., 1996, 35, 290.
5. Kagawa K., Fujitaka K., Isobe T., Yamasaki M., Miyazaki M., Oguri T., Kohno N.: "Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion". Intern. Med., 2001, 40, 1020.
6. Ishii K., Aoki Y., Sasaki M., Tanaka K.: "Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cisplatin chemotherapy". Gynecol. Oncol., 2002, 87, 150.
7. Schwartz W.B., Bennett W., Curelop S., Bartter F.C.: "A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone" Am. J. Med., 1957, 23, 529.
8. Kurtzberg J., Dennis V.W., Kinney T.R.: "Cisplatinum-induced renal salt wasting". Med. Pediatr. Oncol, 1984, 12, 150.
9. Langer-Nitsche C., Luck HJ., Heilmann M.: "Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer". Acta Oncol., 2000, 39, 1001.
10. Resnik E., Bender D.: "Syndrome of inappropriate antidiuretic hormone secretion in papillary serous surface carcinoma of the peritoneum". J. Surg. Oncol., 1996, 61, 63.
11. Ozols R.F., Bundy B.N., Greer B.E., Fowley J.M., Clarke-Pearson D., Burger R.A. et al.: "Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group Study". J. Clin. Oncol., 2003, 21, 3194.